top of page

What We Do

Global Burden of

Hip Fractures

trends in incidence, post-fracture treatment, and mortality

Hip fracture is a public health burden leading to high morbidity and mortality. To inform health initiatives for improving patient outcomes, longitudinal and cross-geographical comparisons of health data can provide insights on aetiology, risk factors, and effectiveness of healthcare practices. Global reports of disease are typically systematic reviews based upon many studies representing a heterogeneity of methods, sample sizes, and study periods; thus making it a challenge to interpret the report variation between countries. Dr. Lung Cheung, Dr. Wing Sing and Professor Wong at the Department of Pharmacology and Pharmacy at The University of Hong Kong are leading a study of hip fractures using a standardized methodology applied to large databases of health records within geographies of Asia, Oceania, North and South America, Western and Northern Europe.

 

White Structure

Research Objectives

Bar Chart

Annual incidence of Hip fractures

To estimate the annual incidence of hip fractures, and evaluate the trend during 2005 - 2018 

Image by National Cancer Institute

Pharmacological Treatment for Fracture Prevention

To investigate the proportion of patients receiving treatment within 12 months following their initial hip fracture

X-Ray Results

Mortality rate of hip fracture

To examine the mortality rate of patients with hip fractures within 12 months following their initial hip fracture

Get in touch with us.

General Office, L02-56,
2/F, Laboratory Block,
LKS Faculty of Medicine,
The University of Hong Kong,
21 Sassoon Road,
Pokfulam, Hong Kong SAR.

You can email us.

Complete the form below and we will get back to you very soon.

bottom of page